Literature DB >> 15034913

Alcohol-withdrawn animals have a prolonged increase in dopamine D2high receptors, reversed by general anesthesia: relation to relapse?

Philip Seeman1, Teresa Tallerico, Françoise Ko.   

Abstract

The biochemical basis for alcohol addiction and relapse is not known. Although ethanol promotes the release of dopamine like other drugs of abuse, many unknown factors remain to be investigated concerning the biochemical abnormalities which persist after ethanol drinking and which contribute to alcohol relapse. Although ethanol withdrawal is associated with enhanced sensitivity to dopamine in animals and humans, only minor changes in the striatal density of dopamine D2 receptors have been found in humans, and animals show a small reduction in striatal D2 receptors. But how can dopamine-related functions be increased in ethanol withdrawal in the face of an unchanged or reduced density of dopamine D2 receptors? Considering that ethanol sensitizes rats to amphetamine, and that the high-affinity state of D2, or D2High, is markedly increased in striata from amphetamine-sensitized rats, we measured the density of D2High in striata from rats withdrawn from ethanol. These sites were elevated by 360% (7.2 pmol/g) for at least 8 days after stopping ethanol and returned to normal levels of 2 pmol/g after 2 weeks of ethanol withdrawal. In addition, 1 h of deep general anesthesia given 5 days into withdrawal resulted in a normal level of D2High within 24 h. Because the D2High states are the functional form of D2, their elevated density in ethanol withdrawal may be related to ethanol relapse in humans. General anesthesia may alleviate aspects of alcohol or amphetamine abuse or psychosis associated with elevated D2High. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15034913     DOI: 10.1002/syn.20005

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  7 in total

1.  Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis.

Authors:  Philip Seeman; David Weinshenker; Remi Quirion; Lalit K Srivastava; Sanjeev K Bhardwaj; David K Grandy; Richard T Premont; Tatyana D Sotnikova; Patricia Boksa; Mufida El-Ghundi; Brian F O'dowd; Susan R George; Melissa L Perreault; Pekka T Männistö; Siobhan Robinson; Richard D Palmiter; Teresa Tallerico
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-16       Impact factor: 11.205

Review 2.  Imaging the high-affinity state of the dopamine D2 receptor in vivo: fact or fiction?

Authors:  Mette Skinbjerg; David R Sibley; Jonathan A Javitch; Anissa Abi-Dargham
Journal:  Biochem Pharmacol       Date:  2011-09-16       Impact factor: 5.858

3.  Isoflurane anaesthesia differentially affects the amphetamine sensitivity of agonist and antagonist D2/D3 positron emission tomography radiotracers: implications for in vivo imaging of dopamine release.

Authors:  Patrick Neil McCormick; Nathalie Ginovart; Alan A Wilson
Journal:  Mol Imaging Biol       Date:  2011-08       Impact factor: 3.488

4.  Dopamine and N-methyl-D-aspartate receptor expression in peripheral blood of patients undergoing alcohol withdrawal.

Authors:  T Biermann; D Bönsch; U Reulbach; J Kornhuber; S Bleich
Journal:  J Neural Transm (Vienna)       Date:  2007-03-19       Impact factor: 3.575

5.  Cocaine self-administration produces a persistent increase in dopamine D2 High receptors.

Authors:  Lisa A Briand; Shelly B Flagel; Philip Seeman; Terry E Robinson
Journal:  Eur Neuropsychopharmacol       Date:  2008-03-04       Impact factor: 4.600

Review 6.  The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction.

Authors:  James P Burkett; Larry J Young
Journal:  Psychopharmacology (Berl)       Date:  2012-08-11       Impact factor: 4.530

Review 7.  Hunting for the high-affinity state of G-protein-coupled receptors with agonist tracers: Theoretical and practical considerations for positron emission tomography imaging.

Authors:  Vladimir Shalgunov; Aren van Waarde; Jan Booij; Martin C Michel; Rudi A J O Dierckx; Philip H Elsinga
Journal:  Med Res Rev       Date:  2018-11-18       Impact factor: 12.944

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.